Humana stock sinks again as Medicare Advantage rate shock keeps HUM under pressure
Humana shares fell 6.7% to $194.01 on Wednesday after CMS proposed a 0.09% average payment increase for Medicare Advantage plans in 2027. Investors had expected a larger boost and are now watching for Humana’s Feb. 11 results and the April 6 final rate notice. UnitedHealth also warned of possible benefit cuts if the proposal stands.